The SOD1 Gene Amyotrophic Lateral Sclerosis Type 1 Genetic Test is a specialized diagnostic tool used to identify mutations in the SOD1 gene, which are linked to the development of Amyotrophic Lateral Sclerosis (ALS) type 1. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to muscle weakness and, eventually, severe disability. The SOD1 gene plays a crucial role in encoding a protein that protects the body from damage caused by free radicals. Mutations in this gene can lead to the dysfunction of motor neurons, contributing to the onset of ALS.
This genetic test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing it to detect any abnormalities in the SOD1 gene that may indicate a predisposition to ALS type 1. The process is designed to be straightforward and minimally invasive, with results that can provide crucial information for individuals with a family history of ALS or those exhibiting symptoms of the disease.
The cost of the SOD1 Gene Amyotrophic Lateral Sclerosis Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full analysis and a comprehensive report that explains the findings. The test is an invaluable resource for those seeking early detection and intervention strategies, potentially offering individuals and their families peace of mind and the ability to plan for the future with a better understanding of their genetic health landscape.
The TARDBP gene, known for its role in encoding the TAR DNA-binding protein 43 (TDP-43), has been closely linked with Amyotrophic Lateral Sclerosis (ALS), specifically identified as ALS type 10. This form of ALS is characterized by its genetic origin, where mutations in the TARDBP gene lead to the development of the disease. The TDP-43 protein is crucial for the regulation of gene expression in the nervous system and its mutation can result in the progressive neurodegenerative disorder that ALS is known for, affecting motor neurons and leading to severe physical disability over time.
To diagnose and potentially predict the risk of developing ALS type 10, genetic testing targeting the TARDBP gene is available. DNA Labs UAE offers this specialized test, providing a crucial tool for individuals with a family history of ALS or those experiencing early symptoms of motor neuron diseases. The test involves analyzing the individual's DNA to identify mutations in the TARDBP gene that are associated with ALS type 10.
The cost of the TARDBP Gene Amyotrophic Lateral Sclerosis Type 10 Genetic Test at DNA Labs UAE is 4400 AED. This test is not only significant for diagnosis but also for family planning and understanding the risk of ALS in future generations. It is a critical step in the management and understanding of ALS, offering hope and information to affected individuals and their families.
The FIG4 gene plays a critical role in the development and function of nerve cells, and mutations in this gene have been associated with Amyotrophic Lateral Sclerosis type 11 (ALS11), a subtype of ALS. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe disability.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the FIG4 gene that are linked to ALS11. This test is crucial for individuals with a family history of ALS or those experiencing symptoms suggestive of the disease, as it can provide a definitive diagnosis of ALS11. Early diagnosis is vital for the management of the condition and for informing patients and their families about the progression of the disease, potential treatment options, and genetic counseling.
The cost of the FIG4 gene test for Amyotrophic Lateral Sclerosis type 11 at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the FIG4 gene. The results of this test can help guide clinical decisions and enable a personalized approach to the management of ALS11.
The OPTN Gene Amyotrophic Lateral Sclerosis Type 12 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at identifying mutations in the OPTN gene, which are linked to the development of Amyotrophic Lateral Sclerosis (ALS) Type 12. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.
This genetic test is crucial for individuals with a family history of ALS or those showing symptoms of the disease, as it can provide a definitive diagnosis of ALS Type 12. Early detection through genetic testing allows for better management of the condition, including planning for treatment and supportive care.
The test involves a simple blood draw or a cheek swab, which is then analyzed in the state-of-the-art facilities of DNA Labs UAE. The laboratory employs cutting-edge technology to accurately identify mutations in the OPTN gene, ensuring reliable results.
The cost of the OPTN Gene Amyotrophic Lateral Sclerosis Type 12 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be understated, as it opens the door to targeted treatments and interventions that can significantly improve the quality of life for those affected by this challenging condition.
The SIGMAR1 gene, associated with Amyotrophic Lateral Sclerosis type 16 (ALS16), plays a crucial role in the understanding and diagnosis of this specific form of ALS. Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.
The genetic test for ALS16 focuses on mutations within the SIGMAR1 gene. Identifying these mutations can be pivotal for families with a history of ALS, as it provides crucial information regarding the inheritance pattern, potential risks to other family members, and contributes to the body of knowledge necessary for future therapeutic developments.
DNA Labs UAE offers this specialized genetic testing service. The test is priced at 4400 AED and is conducted in their state-of-the-art laboratory facilities. By opting for this test at DNA Labs UAE, patients and their families can expect a comprehensive analysis of the SIGMAR1 gene, which will aid in the diagnosis of ALS16. This information can be invaluable for making informed decisions about treatment options and managing the disease more effectively.
The KIF7 gene plays a crucial role in the development of various bodily structures, including the limbs, brain, and facial features. Mutations in the KIF7 gene are associated with Acrocallosal syndrome, a rare genetic disorder characterized by craniofacial abnormalities, polydactyly (extra fingers or toes), intellectual disability, and in some cases, agenesis of the corpus callosum, which is the structure connecting the two hemispheres of the brain.
To diagnose Acrocallosal syndrome and confirm its association with mutations in the KIF7 gene, genetic testing is essential. DNA Labs UAE offers a comprehensive genetic test targeting the KIF7 gene to identify mutations linked to Acrocallosal syndrome. This test is pivotal for individuals exhibiting symptoms of the syndrome or those with a family history of genetic disorders.
The cost of the KIF7 gene genetic test at DNA Labs UAE is 3200 AED. This test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect mutations in the KIF7 gene. The results of this test can provide crucial information for diagnosis, management, and genetic counseling for affected individuals and their families.
The ACOX1 gene plays a critical role in the metabolism of fatty acids within the peroxisomes, a specialized compartment in the cell. Mutations in the ACOX1 gene can lead to a rare metabolic disorder known as Acyl-CoA Oxidase Deficiency. This condition disrupts the normal breakdown of long-chain fatty acids, leading to a buildup of toxic substances in the body, which can result in severe neurological and developmental issues.
To diagnose this condition, a genetic test targeting the ACOX1 gene can be conducted. DNA Labs UAE offers this specific test, providing a reliable means of diagnosing Acyl-CoA Oxidase Deficiency. The test involves analyzing the patient's DNA to identify mutations in the ACOX1 gene that are indicative of the disorder.
The cost of the ACOX1 Gene Acyl-CoA Peroxisomal Oxidase Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the advanced technology used in the analysis, and the professional expertise required to interpret the results accurately. Once the test is conducted, healthcare providers can use the results to confirm a diagnosis, which is crucial for developing an effective treatment plan and managing the condition.
The ABCD1 Gene Adrenoleukodystrophy/Adrenomyeloneuropathy Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the ABCD1 gene. These mutations are responsible for a range of genetic disorders, including Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN), which are X-linked conditions affecting the nervous system and adrenal glands. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify any abnormalities in the ABCD1 gene that could lead to these conditions. This test is crucial for early detection and management of ALD and AMN, potentially guiding treatment options and family planning decisions. DNA Labs UAE employs advanced genetic testing technologies to ensure accurate and reliable results, offering a critical resource for individuals and families at risk of these genetic disorders.
The SLC12A6 gene plays a crucial role in the development and function of the nervous system. Mutations in this gene can lead to a rare genetic disorder known as Agenesis of the Corpus Callosum with Peripheral Neuropathy (ACCPN). This condition is characterized by the absence or underdevelopment of the corpus callosum, the part of the brain that connects the two cerebral hemispheres, along with peripheral neuropathy, which affects the peripheral nerves.
To diagnose this condition, a genetic test focusing on the SLC12A6 gene can be conducted. DNA Labs UAE offers this specific genetic test to identify mutations in the SLC12A6 gene that are indicative of ACCPN. The test is crucial for accurate diagnosis and can aid in the management and treatment of the condition.
The cost of the SLC12A6 gene genetic test at DNA Labs UAE is 3200 AED. This test is a vital tool for families and individuals at risk of ACCPN, providing them with essential information for healthcare planning and intervention.
The RNASEH2C gene plays a critical role in the development of Aicardi-Goutieres syndrome type 3, a rare genetic disorder characterized by neurological and immunological abnormalities. Aicardi-Goutieres syndrome can mimic congenital viral infections and leads to a range of symptoms, including developmental delay, microcephaly, and skin lesions, among others. It is an autosomal recessive condition, meaning that an affected individual inherits two defective copies of the gene, one from each parent.
Genetic testing for mutations in the RNASEH2C gene is essential for the accurate diagnosis of Aicardi-Goutieres syndrome type 3. This test involves analyzing the DNA to identify mutations in the RNASEH2C gene that are known to cause the disorder. Early diagnosis through genetic testing can aid in the management of the condition and help inform family planning decisions.
In the UAE, this specific genetic test is available at DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. The cost of the RNASEH2C gene test for Aicardi-Goutieres syndrome type 3 is 4400 AED. This test is crucial for families with a history of the syndrome or who have children showing symptoms indicative of the condition. By opting for this test, parents can gain valuable insights into their child's health and make informed decisions about their care and treatment options.
